OSOM Covid Flu Test Combo 3 in 1 Rapid Home Test Kit 2 Tests

Description

Product Overview

The OSOM Covid Flu Test Combo is a 3‑in‑1 rapid diagnostic solution engineered for home use, combining detection of SARS‑CoV‑2, Influenza A, and Influenza B in a single, easy‑to‑administer kit. Manufactured by Sekisui Diagnostics in the United States, the kit leverages the same lateral flow immunoassay technology trusted by hospitals, clinics, and pharmacies worldwide. Each package contains two self‑contained test devices, a sterile nasal swab, a buffer solution, and step‑by‑step instructions designed for users with no prior laboratory experience. The compact packaging measures 6.06 x 4.41 x 1.34 inches and weighs just 1.76 ounces, making it ideal for storage in a medicine cabinet or travel bag. The test is authorized under the FDA Emergency Use Authorization (EUA), ensuring compliance with rigorous performance standards and providing confidence in the accuracy of results.

Usage

Designed for everyday environments, the OSOM Covid Flu Test Combo can be performed on a kitchen counter, bedside table, or any clean surface. The non‑invasive nasal swab requires only a gentle insertion into each nostril, eliminating the discomfort associated with deeper nasopharyngeal sampling. After swabbing, the user mixes the swab in the provided buffer, applies a few drops to the test cassette, and waits ten minutes for the result window to develop. The clear visual readout displays separate lines for COVID‑19, Flu A, and Flu B, allowing users to interpret results without additional equipment. This simplicity makes the kit suitable for families, travelers, workplaces, schools, and community health programs where quick screening is essential.

Why Choose Us

OSOM stands out in the crowded market of at‑home diagnostics by delivering laboratory‑grade performance in a consumer‑friendly format. The test’s >99% negative predictive value aligns with clinical standards, reducing the likelihood of false‑negative outcomes that could jeopardize public health. Each component undergoes strict quality control, from the precision‑engineered swab tip to the sealed reagent pouch, guaranteeing consistent performance across batches. The kit’s FDA EUA status underscores its reliability during pandemic conditions, while the inclusion of both COVID‑19 and influenza detection addresses the overlapping symptom profiles that often confuse patients and clinicians. Moreover, OSOM provides responsive customer support, offering live chat, email assistance, and a comprehensive online knowledge base to help users troubleshoot any issues that may arise.

Key Features

• Three‑path detection: Simultaneously identifies COVID‑19, Influenza A, and Influenza B from a single nasal swab.
• Fast results: Visual readout appears in just 10 minutes, enabling immediate decision‑making.
• High accuracy: FDA EUA‑authorized performance with >99% accuracy for negative cases.
• User‑friendly design: Step‑by‑step instructions and non‑invasive swab make testing simple for all ages.
• Dedicated support: Access to 24/7 customer service and an online help center for any questions.

FAQ

How accurate is the OSOM Covid Flu Test Combo?

The test is FDA EUA authorized and has demonstrated greater than 99% accuracy for negative results, meeting clinical standards for reliable at‑home screening.

Can I use the test on children?

Yes. The kit is recommended for individuals aged 2 years and older. For children aged 2‑13, an adult should collect the nasal sample to ensure proper technique.

What variants of COVID‑19 does the test detect?

The assay is designed to detect a broad range of SARS‑CoV‑2 variants, including Delta, Omicron, and other circulating strains, providing confidence that emerging mutations are still captured.

How long does the test remain valid after opening?

All components are sealed to maintain stability. Once opened, the test should be performed within the same day to ensure optimal performance.

What should I do if I get a positive result?

Contact your healthcare provider promptly for confirmatory testing and guidance on isolation, treatment, and contact tracing according to local public health recommendations.